Narrative review / 2011
Fasting induces cellular protection and may protect patients against chemotherapy toxicity without chronic weight loss.
This review compares the effects of fasting and dietary restriction on cellular protection and cancer treatment. In mammals, fasting reduces glucose and insulin-like growth factor 1 (IGF-I) levels by over 50%, promoting differential stress resistance between normal and cancer cells. Preliminary reports suggest that fasting for up to 5 days followed by a normal diet may protect patients against chemotherapy without chronic weight loss, whereas long-term dietary restriction (20-40% calorie reduction) requires weeks to months, produces modest changes, and promotes chronic weight loss. The authors state that additional preclinical and clinical studies are required.
- Study type
- Narrative review
- Who was studied
- Cancer patients, rodents, and model organisms
- What was measured
- Cellular protection, glucose, IGF-1 levels, chemotherapy resistance, and weight loss
THE PAPER
Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients.
Lee C, Longo VD. Oncogene, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.